VIRIDIAN THERAPEUTICS INC's ticker is VRDN and the CUSIP is 92790C104. A total of 34 filers reported holding VIRIDIAN THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $4,273,920 | -88.2% | 168,000 | -86.4% | 0.16% | -89.8% |
| Q4 2022 | $36,190,431 | +1.3% | 1,238,974 | -28.9% | 1.53% | +3.5% |
| Q3 2022 | $35,725,000 | +77.0% | 1,741,840 | -0.1% | 1.48% | +51.5% |
| Q2 2022 | $20,178,000 | -37.4% | 1,744,012 | 0.0% | 0.97% | -24.5% |
| Q1 2022 | $32,247,000 | -13.2% | 1,744,012 | -7.2% | 1.29% | -4.4% |
| Q4 2021 | $37,156,000 | +180.9% | 1,879,412 | +133.7% | 1.35% | +161.4% |
| Q3 2021 | $13,228,000 | +106.6% | 804,126 | +129.7% | 0.52% | +115.0% |
| Q2 2021 | $6,403,000 | -17.3% | 350,081 | -24.5% | 0.24% | -17.2% |
| Q1 2021 | $7,745,000 | – | 463,504 | – | 0.29% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VR Adviser, LLC | 2,699,865 | $78,863,057 | 13.28% |
| COMMODORE CAPITAL LP | 2,020,166 | $59,009 | 8.89% |
| ACUTA CAPITAL PARTNERS, LLC | 396,500 | $11,581,765 | 7.13% |
| Fairmount Funds Management LLC | 1,369,623 | $40,006,688 | 6.35% |
| Paradigm Biocapital Advisors LP | 1,751,167 | $51,151,588 | 6.00% |
| Vivo Capital, LLC | 1,678,207 | $49,020 | 5.64% |
| TCG Crossover Management, LLC | 983,610 | $28,731,248 | 5.07% |
| Kynam Capital Management, LP | 1,034,697 | $30,223,499 | 4.64% |
| Octagon Capital Advisors LP | 824,200 | $24,074,882 | 3.75% |
| Logos Global Management LP | 1,000,000 | $29,210,000 | 3.42% |